Accelerating myelofibrosis through loss of Dnmt3a

2Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Jacquelin et al report that loss of DNA methyl-transferase 3A (Dnmt3a) in hematopoietic cells expressing mutant Jak2V617F promotes progression from polycythemia vera to myelofibrosis leading to bone marrow failure and premature mortality.

References Powered by Scopus

Age-related clonal hematopoiesis associated with adverse outcomes

3465Citations
N/AReaders
Get full text

Age-related mutations associated with clonal hematopoietic expansion and malignancies

1479Citations
N/AReaders
Get full text

DNMT3A in Leukemia

148Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Genomic profiling of a randomized trial of interferon-a vs hydroxyurea in MPN reveals mutation-specific responses

38Citations
N/AReaders
Get full text

Synergic crosstalk between inflammation, oxidative stress, and genomic alterations in BCR-ABL-negative myeloproliferative neoplasm

34Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Skoda, R. C. (2018). Accelerating myelofibrosis through loss of Dnmt3a. Blood, 132(26), 2703–2704. https://doi.org/10.1182/blood-2018-11-883470

Readers over time

‘19‘20‘21‘2202468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

67%

Researcher 3

33%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 4

50%

Medicine and Dentistry 2

25%

Materials Science 1

13%

Pharmacology, Toxicology and Pharmaceut... 1

13%

Save time finding and organizing research with Mendeley

Sign up for free
0